Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe. [PDF]
Mazhindu TA +5 more
europepmc +1 more source
Thiopurine Methyltransferase Levels and Azathioprine Outcomes in Thai Patients with Cutaneous Autoimmune Diseases. [PDF]
Pureesrisak P +8 more
europepmc +1 more source
Effects of residue substitutions on the cellular abundance of proteins. [PDF]
Schulze TK, Lindorff-Larsen K.
europepmc +1 more source
Association between genetically predicted expression of TPMT and azathioprine adverse events. [PDF]
Steitz A +14 more
europepmc +1 more source
Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care. [PDF]
Bernsen EC +8 more
europepmc +1 more source
Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance. [PDF]
Pau A +10 more
europepmc +1 more source
Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology. [PDF]
Diekstra MHM +9 more
europepmc +1 more source
Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study. [PDF]
Katabalo DM +7 more
europepmc +1 more source
Pharmacogenomics of treatment toxicities in pediatric B-Cell ALL: toward safer precision therapy. [PDF]
Lameri M +14 more
europepmc +1 more source
Clinical experience in the treatment and prognosis of seven cases of Cronkhite-Canada syndrome. [PDF]
Bae J +6 more
europepmc +1 more source

